Avanos Medical Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 64/207 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 14.00.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Avanos Medical Inc's Score
Industry at a Glance
Industry Ranking
64 / 207
Overall Ranking
175 / 4563
Industry
Healthcare Equipment & Supplies
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
1
analysts
Hold
Current Rating
14.000
Target Price
+13.73%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Avanos Medical Inc Highlights
StrengthsRisks
Avanos Medical, Inc. is a medical technology company focused on delivering medical device solutions. It offers healthcare needs, such as providing nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from surgery to recovery. Specialty Nutrition Systems portfolio of products includes enteral feeding, which consist of MIC-KEY enteral feeding tubes and Corpak patient feeding solutions, and Neonate solutions feeding products consist of NeoMed neonatal and pediatric feeding solutions. It also includes TKO, an anti-reflux needleless connector technology, which is used in Neonatal and Pediatric Intensive Care Units. The Pain Management and Recovery portfolio of products includes surgical pain and recovery products such as ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems and Radiofrequency Ablation solutions, which provide invasive pain relief therapies, such as COOLIEF, Trident and ESSENTEC RFA products.
Fairly Valued
The company’s latest PE is -1.12, at a medium 3-year percentile range.
Institutional Buying
The latest institutional holdings are 44.88M shares, increasing 0.01% quarter-over-quarter.
Avanos Medical, Inc. is a medical technology company focused on delivering medical device solutions. It offers healthcare needs, such as providing nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from surgery to recovery. Specialty Nutrition Systems portfolio of products includes enteral feeding, which consist of MIC-KEY enteral feeding tubes and Corpak patient feeding solutions, and Neonate solutions feeding products consist of NeoMed neonatal and pediatric feeding solutions. It also includes TKO, an anti-reflux needleless connector technology, which is used in Neonatal and Pediatric Intensive Care Units. The Pain Management and Recovery portfolio of products includes surgical pain and recovery products such as ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems and Radiofrequency Ablation solutions, which provide invasive pain relief therapies, such as COOLIEF, Trident and ESSENTEC RFA products.
Ticker SymbolAVNS
CompanyAvanos Medical Inc
CEOPacitti (David)
Websitehttps://avanos.com/
FAQs
What is the current price of Avanos Medical Inc (AVNS)?
The current price of Avanos Medical Inc (AVNS) is 11.410.
What is the symbol of Avanos Medical Inc?
The ticker symbol of Avanos Medical Inc is AVNS.
What is the 52-week high of Avanos Medical Inc?
The 52-week high of Avanos Medical Inc is 17.690.
What is the 52-week low of Avanos Medical Inc?
The 52-week low of Avanos Medical Inc is 9.303.
What is the market capitalization of Avanos Medical Inc?
The market capitalization of Avanos Medical Inc is 529.62M.
What is the net income of Avanos Medical Inc?
The net income of Avanos Medical Inc is -392.10M.
Is Avanos Medical Inc (AVNS) currently rated as Buy, Hold, or Sell?
According to analysts, Avanos Medical Inc (AVNS) has an overall rating of Hold, with a price target of 14.000.
What is the Earnings Per Share (EPS TTM) of Avanos Medical Inc (AVNS)?
The Earnings Per Share (EPS TTM) of Avanos Medical Inc (AVNS) is -10.183.